These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21045761)

  • 1. Rifaximin (Xifaxan 550) for hepatic encephalopathy.
    Med Lett Drugs Ther; 2010 Nov; 52(1350):87. PubMed ID: 21045761
    [No Abstract]   [Full Text] [Related]  

  • 2. Ammonia abolishers: antibiotics for hepatic encephalopathy.
    Felicilda-Reynaldo RF
    Medsurg Nurs; 2012; 21(3):173-5; quiz 176. PubMed ID: 22866441
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifaximin and nonabsorbable disaccharides for hepatic encephalopathy.
    Guslandi M; Cella A
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):376. PubMed ID: 20134260
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy: rifaximin.
    Bajaj JS; Riggio O
    Hepatology; 2010 Oct; 52(4):1484-8. PubMed ID: 20814894
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifaximin: a nonsystemic antibiotic for hepatic encephalopathy.
    Welliver M
    Gastroenterol Nurs; 2013; 36(2):140-2. PubMed ID: 23549218
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifaximin for the treatment of hepatic encephalopathy.
    Mullen K; Prakash R
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):665-77. PubMed ID: 21108586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Rifaximin in prevention of recurrence of hepatic encephalopathy in patients with cirrhosis of liver.
    Ali B; Zaidi YA; Alam A; Anjum HS
    J Coll Physicians Surg Pak; 2014 Apr; 24(4):269-73. PubMed ID: 24709242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin: an alternative for the treatment of hepatic encephalopathy.
    Rigali VT
    Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifaximin for the treatment of hepatic encephalopathy.
    Mantry PS; Munsaf S
    Transplant Proc; 2010 Dec; 42(10):4543-7. PubMed ID: 21168733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):109-11. PubMed ID: 26218792
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q; Jiang XH; Zheng MH; Jiang LM; Chen YP; Wang L
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1064-70. PubMed ID: 19047837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.
    Cottreau J; Baker SF; DuPont HL; Garey KW
    Expert Rev Anti Infect Ther; 2010 Jul; 8(7):747-60. PubMed ID: 20586560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new use for Xifaxan.
    Belavic JM
    Nurse Pract; 2011 Jul; 36(7):8-9. PubMed ID: 21685772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Hepatic Encephalopathy: A Primer.
    Jawaro T; Yang A; Dixit D; Bridgeman MB
    Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting compliance and persistence with treatment for hepatic encephalopathy.
    Neff G
    Pharmacotherapy; 2010 May; 30(5 Pt 2):22S-7S. PubMed ID: 20412037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy?
    Butt NI; Butt UI; Kakar AATK; Malik T; Siddiqui AM
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):115-117. PubMed ID: 29394969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
    MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.
    Mullen KD; Sanyal AJ; Bass NM; Poordad FF; Sheikh MY; Frederick RT; Bortey E; Forbes WP
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1390-7.e2. PubMed ID: 24365449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
    Williams R; Bass N
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S10-8. PubMed ID: 15976747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of once a day rifaximin to twice a day dosage in the prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease.
    Khokhar N; Qureshi MO; Ahmad S; Ahmad A; Khan HH; Shafqat F; Salih M
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1420-2. PubMed ID: 25867912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.